Richard Bakst, MD, is joined by Joshua Brody, MD, and Jonah Shulman, MD, to discuss the management of patients with classic Hodgkin lymphoma. The panelists cover a range of topics, including early stage disease, the benefits of a multimodal approach, PET-driven strategies, and optimal dose of radiation and chemotherapy.
The faculty received modest honoraria from Frontline Medical Communications for their participation in this roundtable. The faculty have no other conflicts of interest to disclose.